Biomarkers can be measured using various techniques, such as blood tests, urine tests, tissue biopsies, and imaging tests. Advances in genomic technologies and proteomics have enabled the identification of a wide range of biomarkers that can be used to tailor treatments to individual patients. For example, next-generation sequencing (NGS) allows for the comprehensive analysis of genetic mutations associated with cancer.
